| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
Sharecare (NASDAQ:SHCR) has been evaluating a range of options including a potential sale of the Company, as well as a reevaluation of potential carveout divestitures and an assessment of Sharecare's strategic direction and continuation as a standalone public company.
Sharecare has been interacting with interested parties, and the Board of Directors formed a special committee of independent directors to evaluate multiple proposals for a potential sale transaction and alternatives thereto. Financial and legal advisors have been retained to assist in the evaluation process.
"Given the disconnect between Sharecare's stock price and the intrinsic value of our company, we believe engaging with parties who have expressed interest in acquiring us is a prudent approach in our efforts to maximize value for our shareholders," said Jeff Arnold, executive chairman and founder of Sharecare. "The board is committed to taking whatever action is in the best interests of shareholders while management continues to be fully committed to the satisfaction of our customers and executing on our strategy and growth plans."
No definitive decisions have been reached regarding strategic alternatives and there is no assurance if or when a transaction may occur. Sharecare will provide an update during its earnings call scheduled for Thursday, March 28, 2024.
Posted In: SHCR
